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Abstract
Purpose: To evaluate the accuracy of Multi-detector row
CT (MDCT) for the prediction of tumor invasion of the
mesorectal fascia (MRF).
Materials and methods: A total of 35 patients with
primary rectal cancer underwent preoperative staging
magnetic resonance imaging (MRI) and MDCT. The
tumor relationship to the MRF, expressed in 3 categories
(1—tumor free MRF = tumor distance ‡ 1 mm;
2—threatened = distance < 1 mm; 3—invasion = dis-
tance 0 mm) was determined on CT by two observers at
patient level and at different anatomical locations. A
third expert reader evaluated the MRF tumor relation-
ship on MRI, which served as reference standard.
Receiver operating characteristic curves (ROC-curves)
and areas under these curves (AUC) were calculated. The
inter-observer agreement of CT was determined by using
linear weighted kappa statistics.
Results: The AUC of CT for MRF invasion was 0.71 for
observer 1 and 0.62 for observer 2. The inter-observer
agreement was kappa = 0.34. The performance of CT at
mid-high rectal levels was statistically significant better
compared to low anterior (obs.1: AUC = 0.88 vs. 0.50;
obs 2: AUC = 0.84 vs. 0.31; P £ 0.040).
Conclusion: Multi-detector row CT has a poor accuracy
for predicting MRF invasion in low-anterior located
tumors.The accuracy of CT significantly improves for
tumors in the mid-high rectum. There is a high incon-
sistency among readers.
Key words: Magnetic resonance imaging—Computed
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The prognosis of patients with rectal cancer has im-
proved since the introduction of total mesorectal excision
(TME) surgery [1–3]. Using this surgical technique the
mesorectal compartment including the rectum and peri-
rectal fat is completely excised by sharp dissection along
the mesorectal fascia (MRF) [1]. Additionally, large
randomized trials have shown that neo-adjuvant therapy
improves local tumor control even further, regardless of
optimized surgical techniques [3, 4]. The advances in
rectal cancer treatment have provoked differentiated
neo-adjuvant treatment strategies based on anatomical
preoperative identifiable risk factors for local tumor
recurrence as can be visualized with magnetic resonance
imaging (MRI) [5]. One of the most important risk fac-
tors is the tumor relationship to the MRF, which actually
defines the surgical circumferential resection margin
(CRM) in TME surgery [6, 7]. Long courses of neo-
adjuvant chemoradiation have emerged as the preferen-
tial treatment of patients with anticipated tumor invasion
of the MRF on MRI in order to downstage/downsize the
tumor and to obtain tumor free resection margins [5].
Magnetic resonance imaging has become an integral
part of the diagnostic work-up of patients with rectal
cancer due to its proven efﬁcacy to determine the tumor
relationship to the MRF [5, 8–11]. However, the mod-
erate availability [12] and the higher cost of MR on one
hand, and improved Multi-detector row CT (MDCT) on
the other hand, have revived the discussion whether to
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of the art CT technique it has become feasible to visualize
the MRF and to perform a quick one stop shop exami-
nation of the whole abdomen including distant metas-
tasis. At present, only a few MDCT studies have been
published on the subject of rectal cancer staging [13–17].
To our knowledge, two studies focused on the prediction
of tumor invasion of the MRF [13, 18]. One study with
MDCT suggested results equal to MRI, and the other
with conventional CT suggested results inferior to MRI.
The question on the accuracy of MDCT remains open.
The application of chemoradiation as the prefered
treatment of locally advanced rectal cancer has created a
major methodological problem for the evaluation of the
staging accuracy of new imaging techniques. Due to the
tumor downsizing the traditional gold standard of his-
tology is no longer valid. Subgroup analysis of patients
treated with short-courses of 5 · 5 Gy radiotherapy (no
downstaging or downsizing effects) or without neo-
adjuvant therapy obviously introduces a selection bias of
small tumors in which imaging of tumor invasion of the
MRF cannot be assessed because there is no invasion.
Therefore, the aim of the present study was to eval-
uate the accuracy of MDCT for the prediction of tumor
invasion of the MRF with MRI as reference standard.
Materials and methods
Patients
Institutional approval was obtained for this retrospective
study. The records of a cohort of consecutive patients
with biopsy proven primary rectal cancer were searched
for patients who underwent both MRI and MDCT
imaging at the University Hospital Maastricht between
June 2004 and June 2006. The standard workup for pa-
tients with a rectal cancer includes a pelvic MRI. Some
patients received a MDCT because of preoperative
planning of radiotherapy. Inclusion criteria were avail-
ability of both MRI and contrast enhanced CT exam-
inations of good quality prior to the application of any
neo-adjuvant therapy. In total, 35 patients met these
inclusion criteria and were enrolled in the present study.
Relevant clinical information such as type of neo-adju-
vant therapy, type of operation, radiologic and histologic
reports were recorded. There were 23 men and 12 wo-
men. The mean age of the patients was 68 years (range
44–85 years). The mean time between the MRI and CT
examination was 24 days (range 1–49 days).
Technique
All CT studies were performed on a 16-slice CT system
(SOMATOM
  Sensation 16, Siemens, Erlangen, Ger-
many). The scan protocol comprised a slice collimation
of 16 · 0.75 mm, table feed/rotation: 15.0 mm, rotation
time 0.5 s, reconstruction increment 5 mm, 5 mm
reconstructed slice thickness. All the patients received
120 ml of nonionic IV contrast agent (Iobitridol 350 mg,
Xenetix  , Guerbet, France) at a flow rate of 3 ml/sec
and oral contrast (Telebrix gastro  , Guerbet). The
images of the pelvis were obtained in the porto-venous
contrast phase (scan delay 60 s). None of the patients
received a contrast enema or bowel relaxation.
Magnetic resonance (MR) imaging was performed on
a 1.5 Tesla system (Gyroscan, Powertrack 6000 NT,
Philips Medical Systems, The Netherlands) using a
phased array sense-cardiac coil. The scan protocol con-
sisted of a T2-weighted sequence obtained in three ori-
entations (axial, sagittal and coronal): turbo(fast)spin
echo, TR = 3427/TE = 150 msec, echo train length of
25, 4 mm slice thickness, 0.8 mm gap, 6 signal averages,
175 · 256 matrix, 20 cm FOV. None of the patients re-
ceived Gadolinium contrast enhanced sequences, fat
suppression tecniques, rectal contrast enema or bowel
relaxation.
Image evaluation
The CT examinations were read by two observers who
were blinded to each other and to the clinical and MRI
results. Observer 1 was a dedicated abdominal radiolo-
gist with over 8 years of experience in reading pelvic CT
and MRI (R.V.). Observer 2 was a general radiologist
with over 5 years of experience in reading cross sectional
imaging (A.D.G). The MRI examinations were assessed
by a third observer with over 12 years experience in
rectal cancer MRI and who has read more than 1500
MRIs of rectal cancer cases (R.B.T).
Observers 1 and 2 assessed the relationship between
the rectal tumor and the MRF on the CT images, and the
third observer on MRI. The MRF was deﬁned as the ﬁne
linear structure surrounding the mesorectal compart-
ment, hypo-intense on T2-weighted MR images and iso-
intense to muscle on CT. The relation of the rectal tumor
to the MRF was expressed in 3 discrete categories:
1 = tumor free MRF deﬁned as a measured distance
between the tumor periphery and the MRF of ‡ 1 mm;
2 = tumor threatened MRF deﬁned as a distance of <
1 mm; 3 = tumor invaded MRF deﬁned as a distance
of = 0 mm between the tumor and the MRF [9, 11]. All
image evaluations and measurements were performed on
a viewing station.
Speciﬁc anatomical locations of the MRF were indi-
vidually evaluated for the presence of rectal cancer and,
if present, the tumor relation to the MRF was assessed
according to the previously described criteria 1–3. Ana-
tomical locations were deﬁned as:
1 Low anterior (anterior mesorectal quadrant at the le-
vel of the prostate and vagina).
2 Low lateral left, posterior and lateral right (lateral and
posterior mesorectal quadrants at the level of the
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low sacrum).
3 Mid anterior in males (anterior mesorectal quadrant at
the level of the seminal vesicles).
4 Mid-high lateral left, posterior and lateral right (lateral
and posterior mesorectal quadrants at the level of the
obturator muscles upto the piriform muscles and hig
sacrum).
Statistical analysis
The CT ﬁndings at patient level and at the level of dif-
ferent anatomical locations were compared with the
corresponding MRI ﬁndings, serving as the reference
standard. Receiver operating characteristic curves (ROC
curves) were constructed and areas under the curves
(AUC) were calculated by using the scored categories 1–
3. The difference in performance of MDCT for the pre-
diction of MRF invasion for different anatomical loca-
tions was analysed by means of comparison of the
corresponding AUC and the calculation of a critical ratio
z according to the method of Hanley [19]. For this
analysis, only anatomical locations with abnormal rectal
walls on MRI were included [19]. A P value of <0.05
was considered as statistically significant. Accuracy,
sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) of CT for the pre-
diction of tumor invasion of the MRF was calculated for
both observers by dichotomization of the scored discrete
categories 1–3 (cutoff between category 1 vs. 2–3). The
inter-observer agreement for CT was determined by
using linear weighted kappa statistics based on the scored
discrete categories 1–3 [20]. Statistical analysis was per-
formed by using the software package SPSS for Win-
dows
 , release 11.5 (Chicago, IL, USA).
Results
Reference standard MRI vs. clinical results
In total, 15 of 35 patients had locally advanced rectal
tumors with tumor invasion of the MRF on MRI. All of
these 15 patients were treated with long courses of
chemoradiation followed by TME in 3 of 15, APR
(abdominal perineal resection) in 2 of 15, pelvic exen-
teration with or without sﬁncter preservation in 8 of 15
and no operation in 2 of 15 patients. The remaining 20 of
35 patients had a tumor free MRF on MRI. About 15 of
these 20 patients received short course radiotherapy
(5 · 5 Gy) followed by TME. Histologic evaluation of
the surgical specimen showed in all of these 15 patiens a
tumor free MRF. The remaining 5 of 20 patients with a
predicted tumor free MRF on MRI received long courses
of chemoradiation based on adverse prognostic risk
factors such as advanced nodal disease and distal loca-
tion. Three of these 5 patients were treated with TME, 1
of 5 with APR and 1 of 5 received no operation.
Performance of CT at patient level
Staging failures of CT for the prediction of tumor inva-
sion of the MRF occurred in 12/35 (34%) patients for
observer 1 and 16/35 (46%) for observer 2 (Table 1). The
majority of these failures were based on the overstaging
of the tumor relation to the MRF (obs 1: 10/12 = 83%;
obs 2: 13/16 = 81%). The area under the ROC curve
(AUC), accuracy, sensitivity, specificity, PPV, and NPV
are displayed in Table 2. The inter-observer agreement
expressed by the linear weighted kappa was 0.34 (95%
CI: 0.04, 0.64).
Analysis of different anatomical locations
The results of CT for the evaluation of tumor invasion at
different anatomical locations are shown in Table 3.
There was a statistically significant difference between
the performance of CT at the mid-high lateral-posterior
rectum compared to the low anterior rectum for both
observers (obs.1: AUC = 0.88 vs. 0.50, P = 0.040; obs
2: AUC = 0.84 vs. 0.31, P = 0.003). Overstaging oc-
curred in 87% (27/31) of the staging failures of CT for
observer 1, 83% (33/40) for observer 2 and were mainly
observed at the lower rectum (Figs. 1, 2). CT failed to
visualize the rectal tumor at 1 of 4 anatomical locations
with tumor invasion of the MRF for observer 1 and 5 of
7 for observer 2 (Fig. 3). Aditionally, observer 1 pre-
dicted in 7 of 120 anatomical locations with a normal
rectal wall on MRI tumor invasion of the MRF and in 11
of 120 for observer 2 (Fig. 4).
Discussion
The present study evaluated the accuracy of MDCT for
the prediction of tumor invasion of the MRF with MRI
as reference standard. We found a poor accuracy (54–
66%), AUC (0.62–0.71) and high inconsistency among
observers for the prediction of tumor invasion of the
MRF. Evaluation of the staging accuracy of CT at dif-
ferent anatomical locations showed very poor AUCs
Table 1. CT vs. reference standard MRI for the prediction of the tumor
relationship to the MRF at patient level.
Free MRF Invaded MRF
a
CT observer 1:
Free 10 2
Threatened 2 1
Invaded 8 12
CT observer 2:
Free 7 3
Threatened 2 -
Invaded 11 12
Total: 20 15
Note: Free MRF = measured distance between tumor and MRF
of ‡ 1 mm. Tumor threatened MRF = distance between tumor and
MRF of <1 mm. Invaded MRF = tumor in contact with MRF
a None of the patients had a tumor threatened MRF on MRI
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signiﬁcantly improved for mid-high lateral-posterior lo-
cated rectal tumors (AUC: 0.84–0.88; P £ 0.04).
Some studies on the performance of MDCT for
staging of rectal cancer have focused on the prediction of
T stage (TNM-staging classiﬁcation) [13–17]. Matsuoka
et al. found in a study of 21 patients comparing MDCT
with MRI an agreement of 95% between MDCT and
histology, with no difference between MDCT and MRI.
Kulinna et al. reported an accuracy of 86% in a study of
92 patients [15]. The results of Sinha et al. showed an
accuracy of 87% for the prediction of T stage in 69 pa-
tients [17]. The study of Taylor et al. addressed the
clinical important prediction of the tumor relationship to
the MRF and reported a poor agreement between
MDCT, MRI and histology (kappa 0.06–0.15) in 42
patients treated with a short course of radiotherapy
(5 · 5 Gy) or surgery only [13]. The NPV of both MRI
and CT was good (82% and 85%), but both modalities
had a very low PPV (25% and 31%).These results con-
firm our findings of overstaging with CT, although the
overstaging of MRI is rather surprising considering the
high accuracy reported in several previous studies [8–11].
The adopted wide cutoff (<5 mm) for the definitition of
tumor threatening and invasion of the MRF might have
been responsible for this substantial overstaging [11].
Wolberink et al. report in a retrospective study of 125
with and without a short course of radiotherapy on the
value of conventional CT in predicting MRF invasion
[18]. The area under the curve of the ROC curve ranged
between 0.697 and 0.813, and is comparable to the
present study. The sensitivity in this study was just below
50%, and the majority of false negatives occurred in tu-
Table 2. Performance of CT for the prediction of tumor invasion of the
MRF at patient level.
Observer 1 Observer 2
AUC (95% CI) 0.71 (0.54, 0.88) 0.62 (0.43, 0.81)
Accuracy 66% (23/35) 54% (19/35)
Sensitivity 87% (13/15) 80% (12/15)
Specificity 50% (10/20) 35% (7/20)
PPV 57% (13/23) 48% (12/25)
NPV 83% (10/12) 70% (7/10)
Note: AUC = Area under the receiver operating characteristic curve;
(95% CI) = 95% confidence interval; PPV = positive predictive value;
NPV = negative predictive value
Table 3. Performance of CT for the prediction of tumor invasion of the
MRF at different anatomical locations.
Locations MRF
invasion
Observer 1 Observer 2
) + AUC (95% CI) AUC (95% CI)
Low anterior 3 8 0.50 (0.10, 0.90)* 0.31 (0.00, 0.64)*
Low lat-post 32 3 0.78 (0.60, 0.97) 0.58 (0.19, 0.96)
Mid anterior 10 7 0.71 (0.46, 0.97) 0.66 (0.35, 0.97)
Mid-high lat-post 77 8 0.88 (0.73, 1.00)* 0.84 (0.66, 1.00)*
All locations** 122 26 0.82 (0.73, 0.92) 0.70 (0.56, 0.84)
Note: AUC = area under the ROC curve with 95% confidence interval;
) = number of cases with a tumor free MRF predicted on MRI;
+ = number of cases with a tumor threatened or invaded MRF
* Statistically significant difference P £ 0.04
** Locations with normal rectal wall on MRI were excluded from
analysis (120/268)
Fig. 1. Poor anatomical detail on CT leading to overesti-
mation of tumor invasion of the MRF in distal rectal tumors. A
Axial MS-CT image of distal rectal cancer. The tumor
(asterisk) is difficult to delineate and no fat pad can be seen
between the tumor and the pelvic floor (arrow) suggesting
invasion of the MRF. B Axial T2-weighted MR image at the
same level shows a tumor free MRF represented by a partial
intact muscular rectal wall layer (arrowhead) and a minimal fat
pad (arrow) inbetween the tumor and the pelvic floor muscles
(double arrow).
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study confirms the difficulty in interpreting these tumors
even on MDCT.
Our results showed a general overstaging of the tumor
relation to the MRF on CT. The main causes were: a poor
localization of the tumor in the rectum, leading to misin-
terpretation of a thickened wall as tumor and vice versa;
inability to detect a (partial) intact muscular rectal wall;
and a poor appreciation of a small fat pad inbetween the
tumor and the MRF. Despite major progress of image
quality with the Multi-detector row technique, its poor
soft tissue contrast resolution compared to MRI remains
[21, 22]. High anatomical detail is essential for the evalu-
ation of distal tumors as we experienced in the majority of
our CT staging failures. Tumor penetration of the distal
rectal wall almost directly results in tumor invasion of the
MRF due to its close relation [23]. This close relation of
anatomy restricts the application of rectal inflation by
Fig. 2. Another example of poor anatomical detail on CT
causing overestimation of MRF invasion in difficult anatomical
regions. A Axial MS-CT image of distal rectal cancer (aster-
isk) showing tumor invasion of the anterior MRF (arrow) and
vagina (v). B Axial T2-weighted MR images at the same level
shows a tumor free anterior MRF and vagina (v) represented
by a well-appreciated fat pad (arrow) between the tumor
(asterisk) and the anterior MRF.
Fig. 3. Difficult visualization of the tumor localization on CT
leading to underestimation of tumor invasion of the MRF. A
Axial MS-CT image. The rectal tumor located in the anterior
rectum (asterisk) at the level of the seminal vesicles (v) is
difficult to appreciate due to partial collapse of the rectal lu-
men and suboptimal soft tissue contrast resolution. B Axial
T2-weighted MR image at the same level illustrates an opti-
mal visualization of the tumor in the rectal wall due to high
anatomical detail. Also the tumor spread into the anterior
MRF (arrows) is well appreciated because of the high soft
tissue contrast resolution (V = seminal vesicles).
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studies in order to better appreciate the tumor location
[14–16].Theinflationoftherectumcausesstretchingofthe
perirectal fat plane and reduces the distance to the MRF
leading to overestimation of tumor invasion [24].
The soft tissue contrast resolution appeared to be far
less critical in the mid-upper rectum, reﬂected by the high
AUCs (0.84–0.88) for both observers, signiﬁcantly better
than for low-anterior rectal tumors. The presence of a
broad non truncated fat manchet surrounding the rectum
at these levels gives sufﬁcient contrast between tumor
and MRF.
A major point of concern is the poor inter-observer
agreement (kappa = 0.34) of CT despite the use of
objective criteria for tumor invasion of the MRF. High
consistency among observers with different levels of
experience is one of the most important pre-requisites for
the general acceptance of a staging technique. The con-
sistent results among observers and repeatedly reported
high accuracy for the prediction of MRF invasion has
contributed to the general acceptance of MRI as the
most appropriate selection tool for neo-adjuvant and
surgical therapy [8, 9, 25].
When considering the results of the present study, one
must keep in mind that the design has some limita-
tions.We used reconstructed CT slices of 5 mm which
were evaluated in the axial plane only. The use of thinner
slices might improve the prediction of MRF invasion in
difﬁcult anatomical regions, however, this has never been
studied. The only reports on this subject have shown
improved T staging by multi planar reconstruction
(MPR) [14, 17]. The main limitation is related to the use
of MRI as the reference standard, rather than histology.
As argued in the introduction this has become virtually
impossible since patients with a tumor that invades or
threatens the MRF are currently treated with long
courses of chemoradiation. Studying only patients who
are treated with surgery only or a short course of pre-
operatieve radiotherapy creates selection bias of non
locally advanced rectal cancer, and excludes those pa-
tients who are most at risk for involvement of the MRF.
[13, 16]. Other authors have compared imaging after neo-
adjuvant chemoradiation with histology, but this is
problematic because of the difficulties in interpreting
radiofibrosis, and does not give an answer to the ques-
tion of the relation of the tumor to the MRF before
chemoradiation [9, 26]. MRI is the only modality that
has been extensively evaluated for the prediction of tu-
mor invasion of the MRF and several studies have
agreed upon its high accuracy [8–11, 25]. Based on the
current evidence, we feel that MRI gives the best avail-
able representation of the tumor extension to the MRF
prior to chemoradiation and therefore could serve as a
reference standard.
Conclusion
Multi-detector row CT has a poor accuracy for the
identiﬁcation invasion of the MRF in low-anterior lo-
cated tumors.The accuracy of CT signiﬁcantly improves
for tumors located in the mid to high rectum. There is a
high inconsistency among readers.
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